These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 16615675)

  • 21. Systemic lupus erythematosus and hydroxychloroquine-related acute intermittent porphyria.
    Esteve-Valverde E; Tapiz-Reula A; Ruiz D; Alijotas-Reig J
    Rheumatol Int; 2020 May; 40(5):777-783. PubMed ID: 31865445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxychloroquine cardiotoxicity: a case-control study comparing patients with COVID-19 and patients with systemic lupus erythematosus.
    Mancuso S; Spinelli FR; Agati L; Ciardi MR; Garufi C; Natalucci F; Molteni E; Truglia S; Riccieri V; Priori R; Mastroianni CM; Conti F
    Clin Exp Rheumatol; 2022 May; 40(5):890-896. PubMed ID: 35383554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxychloroquine in lupus pregnancy.
    Clowse ME; Magder L; Witter F; Petri M
    Arthritis Rheum; 2006 Nov; 54(11):3640-7. PubMed ID: 17075810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Torsade de pointes associated with chloroquine, hydroxychloroquine, and azithromycin: a retrospective analysis of individual case safety reports from VigiBase.
    Saint-Gerons DM; Tabarés-Seisdedos R
    Eur J Clin Pharmacol; 2021 Oct; 77(10):1513-1521. PubMed ID: 33938974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Hydroxychloroquine Use With Decreased Incident Atrial Fibrillation in Systemic Lupus Erythematosus.
    Gupta A; Shields KJ; Manzi S; Wasko MC; Sharma TS
    Arthritis Care Res (Hoboken); 2021 Jun; 73(6):828-832. PubMed ID: 33098269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of hydroxychloroquine and cardiac arrhythmia in patients with systemic lupus erythematosus: A population-based case control study.
    Lo CH; Wang YH; Tsai CF; Chan KC; Li LC; Lo TH; Wei JC; Su CH
    PLoS One; 2021; 16(5):e0251918. PubMed ID: 34015030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus.
    Miyagawa I; Nakano K; Nakayamada S; Iwata S; Hanami K; Fukuyo S; Kubo S; Kawabe A; Miyazaki Y; Inoue Y; Ueno M; Ohkubo N; Fujita Y; Tanaka Y
    Int J Rheum Dis; 2020 Apr; 23(4):549-558. PubMed ID: 32020727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen.
    Bernardini A; Ciconte G; Negro G; Rondine R; Mecarocci V; Viva T; Santini F; de Innocentiis C; Giannelli L; Witkowska E; Locati ET; Castelvecchio S; Marrocco-Trischitta MM; Vicedomini G; Menicanti L; Pappone C
    Int J Cardiol; 2021 Feb; 324():242-248. PubMed ID: 32956782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and Safety of Hydroxychloroquine Therapy for Systemic Lupus Erythematosus Patients Depend on Administration Dose.
    Wakiya R; Kameda T; Nakashima S; Shimada H; Fahmy Mansour MM; Kato M; Miyagi T; Kadowaki N; Dobashi H
    Intern Med; 2020 Sep; 59(17):2105-2112. PubMed ID: 32522920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of generalized pustular psoriasis caused by hydroxychloroquine in a patient with systemic lupus erythematosus.
    Shindo E; Shikano K; Kawazoe M; Yamamoto T; Kusunoki N; Hashimoto Y; Nanki T
    Lupus; 2019 Jul; 28(8):1017-1020. PubMed ID: 31166865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients with Systemic Lupus Erythematosus.
    Hanaoka H; Iida H; Kiyokawa T; Takakuwa Y; Kawahata K
    Intern Med; 2019 May; 58(9):1257-1262. PubMed ID: 30626831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency of Long QT in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine: A Meta-analysis.
    Oscanoa TJ; Vidal X; Kanters JK; Romero-Ortuno R
    Int J Antimicrob Agents; 2020 Dec; 56(6):106212. PubMed ID: 33164789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydroxychloroquine and Chloroquine-Induced Cardiac Arrhythmias and Sudden Cardiac Death in Patients With Systemic Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis.
    Nikolic RPA; Virk MK; Buhler KA; Costenbader KH; Choi MY; Weber BN
    J Cardiovasc Pharmacol; 2024 Aug; 84(2):158-169. PubMed ID: 38922589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases.
    Buchanan NM; Toubi E; Khamashta MA; Lima F; Kerslake S; Hughes GR
    Ann Rheum Dis; 1996 Jul; 55(7):486-8. PubMed ID: 8774170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of Arrhythmia Among New Users of Hydroxychloroquine in Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population-Based Study.
    Hoque MR; Lu L; Daftarian N; Esdaile JM; Xie H; Aviña-Zubieta JA
    Arthritis Rheumatol; 2023 Mar; 75(3):475-484. PubMed ID: 36054570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxychloroquine: a multifaceted treatment in lupus.
    Costedoat-Chalumeau N; Dunogué B; Morel N; Le Guern V; Guettrot-Imbert G
    Presse Med; 2014 Jun; 43(6 Pt 2):e167-80. PubMed ID: 24855048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group.
    Costedoat-Chalumeau N; Amoura Z; Duhaut P; Huong DL; Sebbough D; Wechsler B; Vauthier D; Denjoy I; Lupoglazoff JM; Piette JC
    Arthritis Rheum; 2003 Nov; 48(11):3207-11. PubMed ID: 14613284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines.
    Jorge AM; Melles RB; Zhang Y; Lu N; Rai SK; Young LH; Costenbader KH; Ramsey-Goldman R; Lim SS; Esdaile JM; Clarke AE; Urowitz MB; Askanase A; Aranow C; Petri M; Choi H
    Arthritis Res Ther; 2018 Jul; 20(1):133. PubMed ID: 29976231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discontinuation of antimalarial drugs in systemic lupus erythematosus.
    Wang C; Fortin PR; Li Y; Panaritis T; Gans M; Esdaile JM
    J Rheumatol; 1999 Apr; 26(4):808-15. PubMed ID: 10229401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases.
    Raza HA; Tariq J; Agarwal V; Gupta L
    Rheumatol Int; 2021 Feb; 41(2):257-273. PubMed ID: 33386447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.